Hydroxychloroquine vs Pembrolizumab

## Hydroxychloroquine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Hydroxychloroquine** and **Pembrolizumab**.

## Mechanism of Action

**Hydroxychloroquine**: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Hydroxychloroquine — 40-50 days; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Hydroxychloroquine — C18H26ClN3O; Pembrolizumab — N/A.

**Molecular Weight**: Hydroxychloroquine — 335.8720 g/mol; Pembrolizumab — N/A.

**Type**: Hydroxychloroquine — Small molecule; Pembrolizumab — Antibody.